- Home
- Companies
- canada saskatchewan
- clinical development
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Environmental
- Manufacturing, Other
- Agriculture
- Health and Safety
- Banking & Finance / Insurance / Legal
- Defense
- Aerospace & Air Transport
- Retail
- Waste and Recycling
- Air and Climate
- Soil and Groundwater
- University / Academia / Research
- Food and Beverage
- Energy
- Construction & Construction Materials
Clinical Development Suppliers Serving Saskatchewan
302 companies found
based inPuchheim, GERMANY
Originally founded in 1998 as an independent entity by Horst Lindhofer, we have assisted in the preclinical and clinical development of all Triomab® antibodies that are under development or received market approval, including that of Removab®, the ...
based inGenoa, ITALY
Movendo Technology: the development of clinical technology. Combining research, applied technology and clinical development has allowed Movendo to consolidate a unique position in the global market. Movendo Technology draws on the technical ...
based inMesa, ARIZONA (USA)
BMSEED is a manufacturer of research equipment that replicates in vitro, stretch-induced neurotrauma (e.g. TBI, SCI) for high-content screening of treatment therapies and injury mechanisms in academic research and pharmaceutical settings. The ...
Mechanics Module: strain rate up to 1/s, strain up to 20%. Imaging Module: frame rate: 150fps. Electrophysiology Module: 2x60 channels. Physiological stretch of cells to reproduce the environment of cells inside the body; assessment of cell health, ...
based inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
based inBoca Raton, FLORIDA (USA)
Entero Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing targeted, orally delivered therapies for gastrointestinal (GI) diseases. At the core of its research are three proprietary technologies. Latiglutenase is an ...
Latiglutenase (IMGX003) is an orally administered mixture of two gluten-specific recombinant proteases that degrades gluten proteins into small physiologically irrelevant fragments that is designed to be administered as an adjunct to a gluten-free ...
based inAnyang-si, SOUTH KOREA
Alpinion is located at the pinnacle of the medical industry and is determined to be one of the pillars of a life-long partner for customers, society, and humanity. Each member of ALPINION strives for innovation as an expert and a pioneer in their ...
based inLancaster, CALIFORNIA (USA)
Simulations Plus provides cutting-edge software solutions and consulting services designed to enhance drug discovery, clinical development, and regulatory submission processes. With over 25 years of experience, the company has established itself as ...
based inRegensburg, GERMANY
At lifespin, we digitize biological samples. We create the connection of “life” to the possibilities of the information age. We record very many metabolites simultaneously in one measurement and thus create a “fingerprint” of a person or an organism ...
Facts: Comprehensive biomarker panel with up to 1400 parameters. Unbiased multiparameter quantification. Metabolite profiling in high-throughput (250 samples/24 h). Highly standardized and automated. Reliable, reproducible, cost ...
based inDulles, VIRGINIA (USA)
We are dedicated to improving patient outcomes by developing, supplying and delivering molecular diagnostics and therapeutics (theranostics). The early vision for molecular imaging was to revolutionize clinical diagnostics and therapeutics to better ...
Staying true to our vision to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics, SOFIE has acquired global rights for the diagnostic and companion diagnostic use of the FAPI family of compounds from ...
based inBeijing, CHINA
Chemclin Diagnostics Co., Ltd (hereinafter it was referred to as Chemclin Diagnostics), founded in 2007, is one of the pioneers in developing clinical immunoassays and systems in China. Chemclin Diagnostics is specialized in the research and ...
based inMississauga, ONTARIO (CANADA)
Covalon Technologies Ltd. (Covalon) develops and commercializes proprietary technologies for major medical device manufacturers. Our partners include the top medical device companies, leaders in urology, wound care, vascular access, venture capital, ...
based inShanghai, CHINA
Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation immunotherapies to benefit cancer patients worldwide. Elpiscience has a robust pipeline of globally innovative cancer immunotherapies covering a wide ...
Elpiscience has assembled a global clinical team with a broad range of expertise from designing and leading first-in-human studies to executing large-scale global registration ...
based inHolytown, UNITED KINGDOM
We are developing safer, less expensive CAR-T products which can target more cancers and save more lives. We do this using our integrated model which drives the development of our products through preclinical testing to the clinic. Our mission is to ...
TC BioPharm’s cell banks have been developed as a resource for clinical development of cost-effective, safe and efficacious therapeutic treatments and ultimately, the ability to treat more ...
based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
based inRenfrewshire, UNITED KINGDOM
Terumo Aortic is 100% focused on the aorta, offering a wide range of grafts to address your patient’s unique anatomy. Terumo Aortic is a global medical device company dedicated to developing solutions for aortic and peripheral vascular disease. Our ...
based inNew York, NEW YORK (USA)
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic ...
Medidata AI Integrated Evidence connects historical data from more than 23,000 cross-sponsor clinical trials and 7 million patient volunteers with real world data to deliver powerful insights and the necessary evidence ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process ...
based inChaska,, MINNESOTA (USA)
Lifecore Biomedical is a full-service contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to develop and deliver vital and complex injectable therapies. For more than 30 years, we have ...
Depending upon the requirements of the drug product, a variety of filling conditions can be tested and equipment ...
based inBothell, WASHINGTON (USA)
AGC Biologics offers deep industry expertise and uniquely customized services for the scale-up and cGMP manufacture of protein-based therapeutics (using mammalian and microbial systems), mRNA, pDNA, viral vector and cell therapy products, from ...
based inNaples, FLORIDA (USA)
Enveric Biosciences is leveraging its discovery engine and intellectual property portfolio to identify and build the next generation of psychedelic and cannabinoid medicines for the mind and body. By harnessing the power of synthetic biology and ...
Glioblastoma tumors express CB2 receptors, through which CBD and other cannabinoids are thought to exert their anti-cancer efforts (Ellert-Miklaszewska, Adv Exp Med Biol, 2013). Developing clinical trials to ...
